Chris Stinton

University of Warwick — United Kingdom

Economics, Econometrics and Finance · Social Sciences

23h-index1.8kcitations71works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(17), Economic and Financial Impacts of Cancer(11), Global Cancer Incidence and Screening(7), Metabolism and Genetic Disorders(7), Williams Syndrome Research(7)

Publications69 total

Potential waste in evidence synthesis for health screening: a scoping review and call for action
Journal of Clinical Epidemiology·2025· 1 citedOpen Access
Down Syndrome in British Maternity Care: Mothers' Experiences of Prenatal Testing and Receiving a Prenatal or Postnatal Diagnosis
Journal of Applied Research in Intellectual Disabilities·2025Open Access
Supplementary Methods and Tables from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure S2 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure 3 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Supplementary Methods (Protocol) from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure S1 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure 2 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure S3 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Table 2 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Table 1 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure S4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure 4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure 1 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Figure 5 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
2025Open Access
Down Syndrome in Maternity Care: Mothers' Experiences of Prenatal Screening
American Journal of Medical Genetics Part A·2025· 1 citedOpen Access
The benefits and harms of cancer screening programmes for adults with intellectual disabilities: A systematic review
2025Open Access
Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
Cancer Epidemiology Biomarkers & Prevention·2025· 2 citedOpen Access
Psychological wellbeing in parents of children with Down syndrome: A systematic review and meta-analysis
Clinical Psychology Review·2024· 11 citedOpen Access
Fatigue and vigilance in medical experts detecting breast cancer
Proceedings of the National Academy of Sciences·2024· 15 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Sian Taylor‐Phillips(30), Aileen Clarke(16), Julia Geppert(15), Samantha Johnson(14), Hannah Fraser(13), Karoline Freeman(12), Joanna Moss(7), Chris Oliver(7), Olalekan A. Uthman(5), Patricia Howlin(5), Farah Seedat(5), Matthew J. Randell(5), Jacoby Patterson(4), Bee K. Tan(4), Colin Brown(4), Lena Al-Khudairy(3), Sarah Elison(3), Esther Robinson(3), Noel McCarthy(3), Paul Sutcliffe(3)